[Frontline studies on Duchenne muscular dystrophy treatment]

Masafumi Matsuo
No to Hattatsu. Brain and Development 2009, 41 (2): 92-5
Duchenne muscular dystrophy is the most common inherited muscular disease, characterized by progressive muscle wasting, commonly leading to death in the twenties due to cardiac or respiratory failure. In order to establish treatment for Duchenne muscular dystrophy, many kinds of studies including gene transfer strategies have been conducted, but no effective treatment has been established. Two plausible ways have been proposed. One is the induction of exon skipping to correct out-of-frame to in-frame dystrophin mRNA, thereby leading to the production of truncated dystrophin. The other one is the induction of read-through of nonsense mutation which ignores a premature stop codon to translate dystrophin mRNA into dystrophin. Here, these two ways are presented and discussed.

Full Text Links

Find Full Text Links for this Article


You are not logged in. Sign Up or Log In to join the discussion.

Related Papers

Remove bar
Read by QxMD icon Read

Save your favorite articles in one place with a free QxMD account.


Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"